An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype

John W Whitaker; Robert Shoemaker; David L Boyle; Josh Hillman; David Anderson; Wei Wang; Gary S Firestein

doi:10.1186/gm444

An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype

Genome Med. 2013 Apr 30;5(4):40. doi: 10.1186/gm444. eCollection 2013.

Authors

John W Whitaker¹, Robert Shoemaker², David L Boyle³, Josh Hillman³, David Anderson², Wei Wang¹, Gary S Firestein³

Affiliations

¹ Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA.
² Ignyta, Inc., San Diego, CA, USA.
³ Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, CA, USA.

PMID: 23631487
PMCID: PMC3706831
DOI: 10.1186/gm444

Abstract

Background: A DNA methylation signature has been characterized that distinguishes rheumatoid arthritis (RA) fibroblast like synoviocytes (FLS) from osteoarthritis (OA) FLS. The presence of epigenetic changes in long-term cultured cells suggest that rheumatoid FLS imprinting might contribute to pathogenic behavior. To understand how differentially methylated genes (DMGs) might participate in the pathogenesis of RA, we evaluated the stability of the RA signature and whether DMGs are enriched in specific pathways and ontology categories.

Methods: To assess the RA methylation signatures the Illumina HumanMethylation450 chip was used to compare methylation levels in RA, OA, and normal (NL) FLS at passage 3, 5, and 7. Then methylation frequencies at CpGs within the signature were compared between passages. To assess the enrichment of DMGs in specific pathways, DMGs were identified as genes that possess significantly differential methylated loci within their promoter regions. These sets of DMGs were then compared to pathway and ontology databases to establish enrichment in specific categories.

Results: Initial studies compared passage 3, 5, and 7 FLS from RA, OA, and NL. The patterns of differential methylation of each individual FLS line were very similar regardless of passage number. Using the most robust analysis, 20 out of 272 KEGG pathways and 43 out of 34,400 GO pathways were significantly altered for RA compared with OA and NL FLS. Most interestingly, we found that the KEGG 'Rheumatoid Arthritis' pathway was consistently the most significantly enriched with differentially methylated loci. Additional pathways involved with innate immunity (Complement and Coagulation, Toll-like Receptors, NOD-like Receptors, and Cytosolic DNA-sensing), cell adhesion (Focal Adhesion, Cell Adhesion Molecule), and cytokines (Cytokine-cytokine Receptor). Taken together, KEGG and GO pathway analysis demonstrates non-random epigenetic imprinting of RA FLS.

Conclusions: The DNA methylation patterns include anomalies in key genes implicated in the pathogenesis of RA and are stable for multiple cell passages. Persistent epigenetic alterations could contribute to the aggressive phenotype of RA synoviocytes and identify potential therapeutic targets that could modulate the pathogenic behavior.